Affinity enhancement pretargeting: Synthesis and testing of a 99mTc-labeled bivalent MORF

Molecular Pharmaceutics

Volumn 7, Issue 4, 2010, Pages 1119-1124

  He, Jiang ^a   Wang, Yi ^a   Dou, Shuping ^a   Liu, Xinrong ^a   Zhang, Surong ^a   Liu, Guozheng ^a   Hnatowich, Donald ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

affinity enhancement; bivalent; morpholino; Pretargeting; surface plasmon resonance

Indexed keywords

MORPHOLINE DERIVATIVE; PHOSPHORODIAMIDATE MORPHOLINO; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DEPROTECTION REACTION; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE; SYNTHESIS; TARGET CELL; TUMOR CELL;

EID: 77955249198     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp9002909     Document Type: Article

References (25)

1. Green, D. J.; Pagel, J. M.; Nemecek, E. R.; Lin, Y; Kenoyer, A; Pantelias, A; Hamlin, D. K.; Wilbur, D. S.; Fisher, D. R.; Rajendran, J. G.; Gopal, A. K.; Park, S. I.; Press, O. W. Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates Blood 2009, 114 (6) 1226-35
2. Gold, D. V.; Goldenberg, D. M.; Karacay, H; Rossi, E. A.; Chang, C. H.; Cardillo, T. M.; McBride, W. J.; Sharkey, R. M. A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma Cancer Res. 2008, 68 (12) 4819-4826
3. Zhou, J; Soontornworajit, B; Snipes, M. P.; Wang, Y. Development of a novel pretargeting system with bifunctional nucleic acid molecules Biochem. Biophys. Res. Commun. 2009, 386, 521-525
4. Liu, G; Dou, S; Rusckowski, M; Hnatowich, D. J. An experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effector Mol. Cancer Ther. 2008, 7 (5) 1025-32
5. Mirallie, E.; Sai-Maurel, C.; Faivere-Chauvet, A.; Regenet, N.; Chang, C.-H.; Goldenberg, D. M.; Chatal, J.-F.; Barbet, J.; Thedrez, P. Improved pretargeted delivery of radiolabelled hapten to human tumor xenograft in mice by avidin chase of circulating bispecific antibody Eur. J. Nucl. Med. 2005, 32, 901-909
6. Le Doussal, J. M.; Gruaz-Guyon, A.; Martin, M.; Gautherot, E.; Delage, M.; Barbet, J. Targeting of indium-111 labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice Cancer Res. 1990, 50, 3445-3452
7. Karacay, H.; McBride, W. J.; Griffiths, G. L.; Sharkey, R. M.; Barbet, J.; Hansen, H. J.; Goldenberg, D. M. Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a 99mTc-/188Re-labeled peptide Bioconjugate Chem. 2000, 11, 842-854
8. Cardillo, T. M.; Karacay, H.; Goldenberg, D. M.; Yeldell, D.; Chang, C. H.; Modrak, D. E.; Sharkey, R. M.; Gold, D. V. Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy Clin. Cancer Res. 2004, 10, 3552-3561
9. Goodwin, D. A.; Meares, C. F.; McTigue, M.; Chaovapong, W.; Diamanti, C. I.; Ransone, C. H.; McCall, M. J. Pretargeted immunoscintigraphy: Effect of hapten valency on murine tumor uptake J. Nucl. Med. 1992, 33, 2006-2013
10. Hillairet De Boisferon, M.; Raguin, O.; Thiercelin, C.; Dussaillant, M.; Rostene, W.; Barbet, J.; Pelegrin, A.; Gruaz-Guyon, A. Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model Bioconjugate Chem. 2002, 13, 654-662
11. Boerman, O. C.; van Eerd, J.; Oyen, W. J. G.; Corstens, F. H. M. A 3-Step Pretargeting Strategy to Image Infection J. Nucl. Med. 2002, 42, 1405-1411
12. Barbet, J.; Peltier, P.; Bardet, S.; Vuillez, J. P.; Bachelot, I.; Denet, S.; Olivier, P.; Leccia, F.; Corcuff, B.; Huglo, D.; Proye, C.; Rouvier, E.; Meyer, P.; Chatal, J. F. Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody J. Nucl. Med. 1998, 39, 1172-1178 (Pubitemid 28326146)
13. Gautherot, E.; Rouvier, E.; Daniel, L.; Loucif, E.; Bouhou, J.; Manetti, C.; Martin, M.; Le Doussal, J. M.; Barbet, J. Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten J. Nucl. Med. 2000, 41, 480-487
14. Griffiths, G. L.; Chang, C. H.; McBride, W. J.; Rossi, E. A.; Sheerin, A.; Tejada, G. R.; Karacay, H.; Sharkey, R. M.; Horak, I. D.; Hansen, H. J.; Goldenberg, D. M. Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates J. Nucl. Med. 2004, 45, 30-39
15. Hosono, M.; Hosono, M. N.; Kraeber-Bodere, F.; Devys, A.; Thedrez, P.; Fiche, M.; Gautherot, E.; Barbet, J.; Chatal, J. F. Biodistribution and dosimolecular study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten J. Nucl. Med. 1998, 39, 1608-1613 (Pubitemid 28459897)
16. Mang'era, K. O.; Liu, G.; Wang, Y.; Zhang, Y.; Liu, N.; Gupta, S.; Rusckowski, M.; Hnatowich, D. J. Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications Eur. J. Nucl. Med. 2001, 28, 1682-1689
17. Liu, G.; Mang'era, K.; Liu, N.; Gupta, S.; Rusckowski, M.; Hnatowich, D. J. Tumor pretargeting in mice using 99mTc-labeled morpholino, a DNA analog J. Nucl. Med. 2002, 43, 384-391
18. Liu, G.; Liu, C.; Zhang, S.; He, J.; Liu, N.; Gupta, S.; Rusckowski, M.; Hnatowich, D. J. Investigations of technetium-99m morpholino pretargeting in mice Nucl. Med. Commun. 2003, 24, 697-705
19. He, J.; Liu, G.; Gupta, S.; Zhang, Y.; Rusckowski, M.; Hnatowich, D. J. Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept J. Nucl. Med. 2004, 45, 1087-1095
20. He, J.; Liu, G.; Vanderheyden, J. L.; Dou, S.; Rusckowski, M.; Hnatowich, D. J. Affinity enhancement bivalent morpholino for pretargeting: initial evidence by surface plasmon resonance Bioconjugate Chem. 2005, 16, 338-345 (Pubitemid 40388209)
21. He, J.; Liu, X.; Zhang, S.; Liu, G.; Hnatowich, D. J. Affinity enhancement bivalent morpholino for pretargeting: surface plasmon resonance studies of molecular dimensions Bioconjugate Chem. 2005, 16, 1098-1104 (Pubitemid 41368110)
22. Winnard, P, Jr.; Chang, F; Rusckowski, M; Mardirossian, G; Hnatowich, D. J. Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA Nucl. Med. Biol. 1997, 24 (5) 425-32
23. Liu, G; He, J; Dou, S; Gupta, S; Rusckowski, M; Hnatowich, D. J. Further investigations of morpholino pretargeting in mice - establishing quantitative relations in tumor Eur. J. Nucl. Med. Mol. Imaging 2005, 32 (9) 1115-1123
24. He, J.; Liu, G; Zhang, S; Vanderheyden, J. L.; Liu, N; Liu, C; Zhang, Y; Gupta, S; Rusckowski, M; Hnatowich, D. J. A comparison of in vitro and in vivo stability in mice of two morpholino duplexes differing in chain length Bioconjugate Chem. 2003, 14 (5) 1018-1023
25. He, J.; Liu, G. Z.; Dou, S; Gupta, S; Rusckowski, M; Hnatowich, D. J. An Improved Method for Covalently Conjugating Morpholino Oligomers to Antitumor Antibodies Bioconjugate Chem. 2007, 18, 983-988